Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 1.00 |
| ▸ | MEN1 | O00255 | 2/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 2/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 1.00 |
| ▸ | PGR | P06401 | 5/20 | 0.69 |
| ▸ | AR | P10275 | 5/20 | 0.69 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.69 |
| ▸ | NR3C1 | P04150 | 4/20 | 0.69 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.69 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.69 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.69 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.69 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.69 |
| ▸ | ABCB11 | O95342 | 2/20 | 0.69 |
| ▸ | POLB | P06746 | 1/20 | 0.69 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.55 |
| ▸ | USP2 | O75604 | 2/20 | 0.55 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Melengestrol Acetate SCHEMBL16389279 | 1.00 | LMNA (1.00) | LMNAMEN1KMT2ATDP1PGR | |
| Melengestrol Acetate SCHEMBL15079259 | 1.00 | LMNA (1.00) | LMNAMEN1KMT2ATDP1PGR | |
| Melengestrol Acetate SCHEMBL13778228 | 1.00 | LMNA (1.00) | LMNAMEN1KMT2ATDP1PGR | |
| Melengestrol Acetate SCHEMBL10867312 | 1.00 | LMNA (1.00) | LMNAMEN1KMT2ATDP1PGR | |
| Melengestrol Acetate SCHEMBL31477812 | 0.95 | LMNA (0.91) | LMNAMEN1KMT2ATDP1PGR | |
| SCHEMBL30152035 | 0.90 | LMNA (0.81) | LMNAMEN1KMT2ATDP1PGR | |
| SCHEMBL30291851 | 0.90 | LMNA (0.81) | LMNAMEN1KMT2ATDP1PGR | |
| SCHEMBL8859712 | 0.88 | LMNA (0.78) | LMNAMEN1KMT2ATDP1PGR | |
| SCHEMBL9992871 | 0.87 | LMNA (0.77) | LMNAMEN1KMT2ATDP1PGR | |
| SCHEMBL8859672 | 0.87 | LMNA (0.77) | LMNAMEN1KMT2ATDP1PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 11391 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260116861-A1 | ISOXAZOLE HYDROXAMIC ACIDS AS HISTONE DEACETYLASE 6 INHIBITORS | THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) | 2026-04-30 | — | — | US | claimed |
| US-12522572-B2 | Isoxazole hydroxamic acids as histone deacetylase 6 inhibitors | THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) | 2026-01-13 | — | — | US | claimed |
| EP-4647069-A1 | DRUGS AND COMPOSITIONS FOR USE IN THE TREATMENT OF RETT SYNDROME | UNIVERSITA' DEGLI STUDI DI TRIESTE (IT) | 2025-11-12 | — | — | EP | claimed |
| WO-2025151713-A1 | PROTEIN AND PEPTIDE VACCINES TARGETING METHANOGENS | Arkea Bio Corp. (US) | 2025-07-17 | — | — | WO | claimed |
| WO-2025151711-A1 | NUCLEIC ACID VACCINES TARGETING METHANOGENS | Arkea Bio Corp. (US) | 2025-07-17 | — | — | WO | claimed |
| US-20250222082-A1 | PROTEIN AND PEPTIDE VACCINES TARGETING METHANOGENS | ARKEA BIO CORP (US) | 2025-07-10 | — | — | US | claimed |
| WO-2025128700-A1 | CELL-BASED VACCINES | Arkea Bio Corp. (US) | 2025-06-19 | — | — | WO | claimed |
| CN-120118320-A | Polyester-based multi-block thermotropic shape memory material with adjustable performance and preparation method thereof | 大连理工大学 | 2025-06-10 | — | — | CN | claimed |
| WO-2025085377-A1 | USE OF ZOALENE IN LIVESTOCK | ZOETIS SERVICES LLC (US) | 2025-04-24 | — | — | WO | claimed |
| WO-2025073698-A1 | PROCESS FOR BONDING A METALLIC SURFACE WITH ANOTHER SURFACE | SPECIALTY OPERATIONS FRANCE (FR) | 2025-04-10 | — | — | WO | claimed |
| US-5112614-A | IMPLANTABLE DELIVERY DISPENSER | ALZA CORPORATION (US) | 1992-05-12 | — | — | US | claimed |
| EP-0463454-A2 | Transdermal administration to humans and animals | DERMAMED (IL) | 1992-01-02 | — | — | EP | claimed |
| WO-1991010423-A1 | LONG-TERM DELIVERY DEVICE INCLUDING LOADING DOSE | ALZA CORPORATION (US) | 1991-07-25 | — | — | WO | claimed |
| WO-1991004016-A1 | IMPLANTABLE DELIVERY DISPENSER | ALZA CORPORATION (US) | 1991-04-04 | — | — | WO | claimed |
| EP-0179496-A1 | 16-Sulfinylmethyl-steroids, their preparation and use | THE UPJOHN COMPANY (US) | 1986-04-30 | — | — | EP | claimed |
| US-4443377-A | Isomerization-acylation process | THE UPJOHN COMPANY (US) | 1984-04-17 | — | — | US | claimed |
| EP-0104054-A2 | 16-methylene-steroids and their preparation | THE UPJOHN COMPANY (US) | 1984-03-28 | — | — | EP | claimed |
| US-4346709-A | Drug delivery devices comprising erodible polymer and erosion rate modifier | ALZA CORPORATION (US) | 1982-08-31 | — | — | US | claimed |
| US-4154748-A | Phosphate catalyzed acylation of steroidal tertiary alcohols | THE UPJOHN COMPANY (US) | 1979-05-15 | — | — | US | claimed |
| US-3988447-A | PALLIATIVE TREATMENT OF ENDOMETRIAL CARCINOMA, PROGESTERONES | THE BRITISH DRUG HOUSES LTD. (EN) | 1976-10-26 | — | — | US | claimed |